Emerging Technologies for Identifying Atrial Fibrillation
نویسندگان
چکیده
منابع مشابه
Emerging drugs for atrial fibrillation
Atrial fibrillation (AF) is associated with excess morbidity and mortality, and is the most common reason for arrhythmia-related hospitalization [1]. As a result of an aging population, the prevalence of AF is expected to rise over the next several decades, and as many as 6 million individuals may be affected by the year 2050 in the USA alone [2]. Greater awareness regarding the changing epidem...
متن کاملAtrial fibrillation: an emerging epidemic?
Correspondence to: Jonathan S Steinberg, MD, St Luke’s-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025, USA; [email protected] . . . . . . . . . . . . . . . . . . . . . . . A trial fibrillation (AF) is the most common arrhythmic condition facing physicians, afflicting almost 1 in 20 people over the age of 60. The prevalence of AF is on the rise, due, in part, to an aging ge...
متن کاملAtrial Fibrillation: an Emerging Epidemic
ed that in 2010 there were ≈2.7 million to 6.1 million cases of AF. The incidence of AF is expected to increase by between ≈5.6 and 12 million by 2050.6 AF is strongly associated with age, gender, race and the presence of cardiovascular disease. In the Medicare population, numerous chronic conditions are associated with the incidence of AF. These include hypertension, obesity, diabetes, chronic...
متن کاملNew technologies in atrial fibrillation ablation.
Atrial fibrillation (AF) is a major public health issue worldwide, the incidence of which is likely to continue to rise. With the birth of pulmonary vein isolation(PVI), cardiac ablation has emerged as key strategy for the treatment of AF. PVI using traditional point by point radiofrequency ablation is time consuming and technically challenging. Refining patient selection for PVI also remains a...
متن کاملNew Technologies In Atrial Fibrillation Ablation
Introduction Atrial fibrillation(AF) remains the most common sustained arrhythmia in the United States affecting greater than 3 million individuals, a number likely to rise dramatically by 2015.1 AF is associated with symptoms such as a palpitations, lightheadedness, fatigue, and may precipitate heart failure. In addition, it has been associated with an increased risk for stroke, increased hosp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation Research
سال: 2020
ISSN: 0009-7330,1524-4571
DOI: 10.1161/circresaha.119.316342